EKG vs HEAL: Holdings Overlap & Returns
Over the year to Nov 13, 2026, EKG returned +21.3% to HEAL's +0.2%; 47% of their weight is in the same names.
- Return gap
- +21.1 pts1 year to Nov 13, 2026: EKG ahead, total return
- Fee gap
- 0.15 ptsA year: EKG 0.65%, HEAL 0.50%, per filings dated Jan 28, 2026 and Mar 27, 2026
- Overlap
- 47%Share of the two books held in common, holdings dated Nov 12, 2026 and Nov 11, 2026
- Net flow
- –Needs daily flows for both funds
Compare two other funds
Growth of 100
Drawn from the numbers on this page. Growth of 100, both funds, distributions reinvested
EKG +21.3%, HEAL +0.2%: EKG +21.1 pts ahead, 1 year, Nov 13, 2025 to Nov 13, 2026.
ShareUse this comparison
Cost to trade
Hypothetical. A $10,000 order in EKG costs about $13.50 one way and $27.00 in and out, at a median spread of 0.27%. The 0.27% spread is EKG’s 30-day median, from First Trust (fund page).
Fees over time
Hypothetical. $10,000 in EKG for 10 years at 0.65% a year costs about $1,068 in fees and lost growth; HEAL at 0.50% would cost $827. Assumes 6% a year before fees, a sample rate, not a forecast.
How each fund moved
43% of EKG's weight is in S&P 500 companies and 58% is outside the index. Holdings as of Nov 12, 2026.
27% of HEAL's weight is in S&P 500 companies and 73% is outside the index. Holdings as of Nov 11, 2026.
Key numbers
HEAL costs 0.15 points a year less; their one-year returns differ by 21.1 points; HEAL is 4.1 times larger.
Pair scorecard
Open the table
Points (pts) are percentage points.
| Total return, 1 year | +21.3% | +0.2% |
|---|---|---|
| Below its all-time high | 10.1%, high on Oct 29, 2026 | 55.5%, high on Feb 12, 2021 |
| What it tracks | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| Expense ratio | 0.65% | 0.50% |
| Net assets, as of Nov 11, 2026 | $9.2m | $38m |
| Holdings in common | 47% |
The numbers behind it
Net assets: $9.1m on Nov 12, 2026 for First Trust Nasdaq Lux Digital Health Solutions ETF, and $38m on Nov 11, 2026 for Global X HealthTech ETF.
Holdings in common uses holdings dated Nov 11, 2026 and Nov 12, 2026.
What they share
By the books each fund has filed, EKG and HEAL hold 47% of their money in the same securities at the same weight. Holdings dated Nov 11, 2026 and Nov 12, 2026.
half
47% in common
Held in common
Show all 12 holdings
| Veeva Systems Inc. (Class A) | 8.20% | 6.13% |
| IQVIA Holdings Inc. | 8.04% | 6.00% |
| DexCom, Inc. | 6.93% | 4.51% |
| ResMed Inc. | 3.85% | 4.00% |
| Intuitive Surgical, Inc. | 9.05% | 3.38% |
| Tempus AI, Inc. (Class A) | 3.11% | 4.98% |
| Insulet Corporation | 3.19% | 2.96% |
| Oscar Health, Inc. (Class A) | 2.90% | 5.62% |
| Hinge Health, Inc. (Class A) | 2.68% | 3.24% |
| Heartflow, Inc. | 1.48% | 3.21% |
| Hims & Hers Health, Inc. | 1.40% | 2.62% |
| Doximity, Inc. (Class A) | 1.29% | 3.37% |
Only in EKG
Show all 8 holdings
| Natera, Inc. | 7.78% |
| Illumina, Inc. | 3.80% |
| Guardant Health, Inc. | 3.77% |
| QIAGEN N.V. | 3.64% |
| Align Technology, Inc. | 3.23% |
| Globus Medical, Inc. (Class A) | 3.19% |
| GRAIL, Inc. | 1.79% |
| Twist Bioscience Corporation | 1.77% |
Only in HEAL
Show all 8 holdings
| PRO MEDICUS LTD | 4.98% |
| GE HEALTHCARE TECHNOLOGY | 4.66% |
| KONINKLIJKE PHILIPS NV | 3.94% |
| DEMANT A/S | 3.71% |
| ALIBABA HEALTH INFORMATION T | 1.90% |
| RECURSION PHARMACEUTICALS-A | 1.48% |
| CLOVER HEALTH INVESTMENTS CO | 1.46% |
| NURIX THERAPEUTICS INC | 1.27% |
Side by side
Open the table
| Fund | First Trust Nasdaq Lux Digital Health Solutions ETF · Holds 51 stocks in healthcare innovation and GLP-1, 42% of its weight in S&P 500 companies | Global X HealthTech ETF · Holds 39 stocks in healthcare innovation and GLP-1, 27% of its weight in S&P 500 companies |
| Issuer | First Trust | Global X |
| Theme | Healthcare innovation and GLP-1 | Healthcare innovation and GLP-1 |
| In the S&P 500 | 42.5% | 27.0% |
| Active share vs the S&P 500 | 99.6% | 99.6% |
| In the Nasdaq-100 | 16.0% | 7.9% |
| Holdings | 51 | 39 |
| Top ten, share of the fund | 58.3% | 48.6% |
| Expense ratio | 0.65% | 0.50% |
| Fee for the differing part | 0.65% | 0.50% |
| Total return, 1 year | +21.3% | +0.2% |
| vs its benchmark | not measured | not measured |
| Below its high | −10.1% | −55.5% |
| Net assets, EKG as of Nov 12, 2026 and HEAL as of Nov 11, 2026 | $9.1m | $38m |
As of Nov 13, 2026. Source: ETFIQ.
Window by window
Open the table
| 3 months | +6.7% | +2.9% |
|---|---|---|
| 6 months | +43.1% | +24.6% |
| 1 year | +21.3% | +0.2% |
| 3 years | +69.3% | +15.7% |
| Since launch (Not the same days: EKG Mar 2022 · HEAL Jul 2020) | +13.3% | −35.3% |
About EKG
By weight, 42% of EKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 58% of the fund across 51 positions, as published by its issuer for Nov 12, 2026.
More
Over the year to Nov 13, 2026 the fund returned +21.3% with distributions reinvested. It sits 10.1% below its all-time high of Oct 29, 2026.
About HEAL
By weight, 27% of HEAL's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 49% of the fund across 39 positions, as published by its issuer for Nov 11, 2026.
More
Over the year to Nov 13, 2026 the fund returned +0.2% with distributions reinvested. It sits 55.5% below its all-time high of Feb 12, 2021.
47% of the two portfolios are the same securities at the same weight.
Questions people ask
Do EKG and HEAL hold the same stocks?
By their latest filings, 47% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Other comparisons
Sources
More
Links are sources, not endorsements. A comparison is not a recommendation.
Copy and cite
Cite this pageCitation, APA and Markdown
ETFIQ, EKG against HEAL, data as of Nov 13, 2026. https://etfiq.com/compare/themes/ekg-vs-heal
ETFIQ. (Nov 13, 2026). EKG against HEAL. Retrieved from https://etfiq.com/compare/themes/ekg-vs-heal
[EKG against HEAL (ETFIQ, Nov 13, 2026)](https://etfiq.com/compare/themes/ekg-vs-heal)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.